20 February 2025
The team has just received pre-maturation funding from Cancéropôle PACA for its project to validate a biomarker predictive of the eligibility of patients with acute myeloid leukemia (AML) for treatment with menin inhibitors.
news from the crcm
10 February 2025
We are delighted to welcome Josephine Shabani, a Master 2 student at the University of Verona (Italy), who has recently joined our team.
10 February 2025
This publication in Cell reveals how two distinct E3 ligases target BACH1 quaternary degrons under oxidative stress, in collaboration with several research teams.
28 January 2025
The "Control of structure-specific endonucleases and genome stability" team (Gaillard team) is proud to receive support from the Ligue Nationale Contre le Cancer.
28 January 2025
HU LUCA-pi on lung cancer prevention, PEPR Santé Numérique DIGPHAT for pharmacology modeling and the SouthRock consortium, an alliance with the CRCL to combat pediatric cancers.
28 January 2025
Welcome to Elias Ventre and Quentin Marcou, who join the COMPO team, headed by Drs Benzekry and Ciccolini, as Research Associates.
28 January 2025
Thanks to the Pancreas-View tool, personalized treatment for pancreatic cancer is becoming a reality. By integrating artificial intelligence and molecular signatures, this tool promises to improve treatment efficacy and patient survival.
28 January 2025
Pancreatic cancer, one of the most aggressive cancers, is at the heart of the COMBAT-PDAC project, supported by Europe and the ANR. The aim is to personalize treatments using innovative models and identify biomarkers to improve patient survival.
28 January 2025
Recent publications by the Modesti team in Nat. Struct. Mol. Biol. and Nucleic Acids Res. reveal new DNA repair mechanisms, highlighting the role of disordered regions of XRCC4/XLF and the impact of Lig3 and Lig4 on cell viability.
28 January 2025
Our research team has nurtured brilliant minds that have contributed to groundbreaking discoveries before embarking on exciting new paths.
28 January 2025
Published in Genes & Development, the Coulon team's study identifies a heterozygous variant of RPA2 as a new cause of disorders in telomere biology, impacting their stability and regulation.
28 January 2025
The MarMaRa Institute, which brings together over 30 interdisciplinary research teams, now welcomes the Telomeres and Chromatin team. This partnership will strengthen research into rare diseases, combining genetics, systems biology and therapeutic innovations to improve diagnosis and treatment.